Nicla La Verde

Research Interests

Explore related searches

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (15)

Collaborators (6)

eriseld krasniqi

David J. Pinato

Imperial College London

UNITED KINGDOM

Alessio Cortellini

Imperial College London

UNITED KINGDOM

ida paris

Head of Breast Oncology Unit

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Chara Stavraka

NIHR Clinical Lecturer

King’s College London

UNITED KINGDOM

Rossana Berardi

Associate Professor

Università Politecnica delle Marche

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Nicla La Verde

Research Interests

Explore related searches

Contact this professor

Articles (15)

Collaborators (6)

eriseld krasniqi

David J. Pinato

Alessio Cortellini

ida paris

Chara Stavraka

Rossana Berardi

Make your next move.

Nicla La Verde

Research Interests

Explore related searches

Contact this professor

Articles (15)

Author Correction: Real-world ANASTASE study of atezolizumab+nab-paclitaxel as first-line treatment of PD-L1-positive metastatic triple-negative breast cancer

Rising Concern About the Carcinogenetic Role of Micro-Nanoplastics

Hospital-Based Influenza and Pneumococcal Vaccination for Cancer Patients on Active Treatment and Their Family Members during the COVID-19 Pandemic in Italy: A Single-Center Experience

<i>Ralstonia insidiosa</i> Bacteremia in Patients with Solid Cancer Treated by Means of a Central Venous Catheter

Adjuvant capecitabine in triple negative breast cancer patients with residual disease after neoadjuvant treatment: real-world evidence from CaRe, a multicentric, observational study

Codon-specific KRAS mutations predict survival benefit of trifluridine/tipiracil in metastatic colorectal cancer.

Host-Related Factors in the Interplay among Inflammation, Immunity and Dormancy in Breast Cancer Recurrence and Prognosis: An Overview for Clinicians

Real-world ANASTASE study of atezolizumab+nab-paclitaxel as first-line treatment of PD-L1-positive metastatic triple-negative breast cancer

Cancer care in transgender and gender-diverse persons: results from two national surveys among providers and health service users by the Italian Association of Medical Oncology

Clinical efficacy of the first two doses of anti-SARS-CoV-2 mRNA vaccines in solid cancer patients

Immunogenicity of two doses of BNT162b2 and mRNA-1273 vaccines for solid cancer patients on treatment with or without a previous SARS-CoV-2 infection

Author Correction: Real-world ANASTASE study of atezolizumab+nab-paclitaxel as first-line treatment of PD-L1-positive metastatic triple-negative breast cancer

Alarming Drop in Early Stage Colorectal Cancer Diagnoses After COVID-19 Outbreak: A Real-World Analysis from the Italian COVID-DELAY Study

Evaluation of COVID-19 impact on DELAYing diagnostic-therapeutic pathways of lung cancer patients in Italy (COVID-DELAY study): fewer cases and higher stages from a real-world scenario

Collaborators (6)

eriseld krasniqi

David J. Pinato

Alessio Cortellini

ida paris

Chara Stavraka

Rossana Berardi

Make your next move.